N&PD Moderators: Skorpio
You should upgrade or use an alternative browser.Ketamine salts solubility
sekio
Bluelight Crew
I think Dave Nichols beat you to it, by several years.
It would help if you put the ends of the bonds where they're supposed to be and not in the middle of nowhere? If you ask nicely, I'll send you a copy of ChemDraw.AlsoTapered
Bluelighter
Chem3D was the element I used the most... but I guess if someone presumes PEAs are flat, ChemDraw is sufficient. The only annoying thing I found was that if you made the minimum-energy conformation calculations too granular, Chem3D could chug away for a fair time... but obviously not with such low MW compounds.MedicinalUser247
Bluelighter
My guess would be that the bulk there would abolish activity. LSD is pretty optimized for the serotonin 2A receptor, hence there not being too many changes that gain or even preserve activity.
The bulk where the pentyl chain of THC would be would decrease activity. The active cannabinoid in Radula marginata, perrottetinene has a phenethyl group, which aproximates the length of the pentyl in THC, but is a partial agonist. Adding even more bulk would be inactive at CB receptors (especially with that dimethylamine at the end. That would totally ruin the hydrophobic interactions that the CB receptors require.
Unfortunately all of the bulk of the THC portion of the molecule would likely abolish 5HT2A binding. DMT itself can't take much more than a methoxy at the 5 position, and 6 position modifications seem to abolish activity of tryptamines.
Triptans are the tryptamines with the most bulk on the phenyl ring. They have some serotonergic activity as antimigrane drugs, but are not psychadelic. The prototypical triptan, sumatriptan, is 5-N-methyl-methanesulfonamide-DMT, and that substituient is much smaller than the THC portion you have suggested. It also is highly charged and an H-bonder, so it is even more likely that molecule would be inactive.
Your second compound actually exists, as it was made by Shulgin in PIHKAL (it was kind of a side note in the MDA entry). It is called Alpha, and has some mild dreamyness, with no anorexia at any dose tried but not any other notes on it. Seems interesting.
Just a question @MedicinalUser247, but what is your background in drugs/chemistry that makes you interested in this kind of research?MedicinalUser247
Bluelighter
That's cool. If you ever want some resources to self study, I can help you find something.AlsoTapered
Bluelighter
We have posted all manner of useful resources on this thread. But you know how it is with things like medicinal chemistry - 1% inspiration, 99% perspiration. The Useful Links thread has several books and several hundred hot-links to articles that I've added and that's just a fraction of what's there, free. I've done all the heavy-lifting to avoid duplication of effort.
A lot of your resources are pretty high level. I was more thinking like uni level organic chemistry stuff like MIT's open coursewear offering for organic chemistry I. That would allow for Medicinal User to better utilize the wealth of resources that you have provided on the medicinal chemistry front.Ambrisentan
Bluelighter
phenidatazine